{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:33:10Z","timestamp":1792056790236,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoimmune uveitis (AU) lacks targeted therapies beyond immunosuppression. We identified hyodeoxycholate (HDCA), a gut-derived secondary bile acid, as a key immunometabolic regulator in AU. Metabolomics revealed systemic depletion of HDCA and oleic acid (C18:1n9) in AU patients and experimental AU (EAU) mice, correlating with disease severity. HDCA administration effectively attenuated EAU by reducing pro-inflammatory cytokines (IL-1\u03b2, IL-6, and TNF-\u03b1) and elevating IL-10. Mechanistically, HDCA inhibits Farnesoid X Receptor in splenic red pulp macrophages, activating SREBP1c-dependent fatty acid synthase, which enhances oleic acid production. Systemic oleic acid suppresses ocular Th17 responses and promotes M2 macrophage polarization, enhancing anti-inflammatory immunity. These findings define a spleen-to-eye immunometabolic axis driven by HDCA-mediated macrophage reprogramming, positioning HDCA as a promising therapeutic for AU.<\/jats:p>","DOI":"10.1038\/s41418-026-01696-8","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:10:26Z","timestamp":1773238226000},"page":"1798-1813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut-derived hyodeoxycholate reprograms the spleen\u2013eye immunometabolic axis to suppress autoimmune uveitis"],"prefix":"10.1038","volume":"33","author":[{"given":"Yitao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickie","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9428-5972","authenticated-orcid":false,"given":"Gerry","family":"Melino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2303-0494","authenticated-orcid":false,"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-0458","authenticated-orcid":false,"given":"Xiaolu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-8994","authenticated-orcid":false,"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","volume":"478","author":"P Prasad","year":"2023","unstructured":"Prasad P, Verma S, Surbhi, Ganguly NK, Chaturvedi V, Mittal SA. Rheumatoid arthritis: advances in treatment strategies. Mol Cell Biochem. 2023;478:69\u201388.","journal-title":"Mol Cell Biochem"},{"key":"1696_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","volume":"29","author":"J Vandewalle","year":"2018","unstructured":"Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018;29:42\u201354.","journal-title":"Trends Endocrinol Metab"},{"key":"1696_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1210\/endrev\/bnad016","volume":"44","author":"R Pofi","year":"2023","unstructured":"Pofi R, Caratti G, Ray DW, Tomlinson JW. Treating the side effects of exogenous glucocorticoids: can we separate the good from the bad? Endocr Rev. 2023;44:975\u20131011.","journal-title":"Endocr Rev"},{"key":"1696_CR4","doi-asserted-by":"crossref","unstructured":"Pizano-Mart\u00ednez O, Mendieta-Condado E, V\u00e1zquez-Del Mercado M, Mart\u00ednez-Garc\u00eda EA, Chavarr\u00eda-\u00c1vila E, Ortu\u00f1o-Sahag\u00fan D, et al. Anti-drug antibodies in the biological therapy of autoimmune rheumatic diseases. J Clin Med 2023;12:3271.","DOI":"10.3390\/jcm12093271"},{"key":"1696_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fimmu.2012.00338","volume":"3","author":"JV Forrester","year":"2012","unstructured":"Forrester JV, Xu H. Good news-bad news: the Yin and Yang of immune privilege in the eye. Front Immunol. 2012;3:338.","journal-title":"Front Immunol"},{"key":"1696_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","volume":"5","author":"YG Jeon","year":"2023","unstructured":"Jeon YG, Kim YY, Lee G, Kim JB. Physiological and pathological roles of lipogenesis. Nat Metab. 2023;5:735\u201359.","journal-title":"Nat Metab"},{"key":"1696_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403921","volume":"11","author":"Y Ao","year":"2024","unstructured":"Ao Y, Guo Y, Zhang Y, Xie L, Xia R, Xu J, et al. Hypoxia-mimicking mediated macrophage-elimination of erythrocytes promotes bone regeneration via regulating integrin \u03b1(v)\u03b2(3)\/Fe(2+)-glycolysis-inflammation. Adv Sci. 2024;11:e2403921.","journal-title":"Adv Sci"},{"key":"1696_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","volume":"19","author":"SK Wculek","year":"2022","unstructured":"Wculek SK, Dunphy G, Heras-Murillo I, Mastrangelo A, Sancho D. Metabolism of tissue macrophages in homeostasis and pathology. Cell Mol Immunol. 2022;19:384\u2013408.","journal-title":"Cell Mol Immunol"},{"key":"1696_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445\u201355.","journal-title":"Nature"},{"key":"1696_CR10","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1084\/jem.20042307","volume":"201","author":"HH Lin","year":"2005","unstructured":"Lin HH, Faunce DE, Stacey M, Terajewicz A, Nakamura T, Zhang-Hoover J, et al. The macrophage F4\/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med. 2005;201:1615\u201325.","journal-title":"J Exp Med"},{"key":"1696_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/09273948.2010.525730","volume":"18","author":"AW Taylor","year":"2010","unstructured":"Taylor AW, Kaplan HJ. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul Immunol Inflamm. 2010;18:488\u201392.","journal-title":"Ocul Immunol Inflamm"},{"key":"1696_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2018.09.004","volume":"339","author":"X Li","year":"2019","unstructured":"Li X, Liang D, Shao H, Born WK, Kaplan HJ, Sun D. Adenosine receptor activation in the Th17 autoimmune responses of experimental autoimmune uveitis. Cell Immunol. 2019;339:24\u20138.","journal-title":"Cell Immunol"},{"key":"1696_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18961-0","volume":"11","author":"RJ Napier","year":"2020","unstructured":"Napier RJ, Lee EJ, Davey MP, Vance EE, Furtado JM, Snow PE, et al. T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. Nat Commun. 2020;11:5406.","journal-title":"Nat Commun"},{"key":"1696_CR14","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s10753-024-02149-5","volume":"48","author":"M Wang","year":"2025","unstructured":"Wang M, Huang X, Shu J, Li H, Yang T, Li N, et al. Irisin alleviates autoimmune uveitis through promoting retinal microglial M1 to M2 phenotypic polarization, mediated by the HIF-1\u03b1 pathway. Inflammation. 2025;48:1716\u201327.","journal-title":"Inflammation"},{"key":"1696_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33:791\u2013803.e797.","journal-title":"Cell Metab"},{"key":"1696_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21744-w","volume":"12","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Zhao A, Ning Z, Kuang J, Wang S, et al. Hyocholic acid species as novel biomarkers for metabolic disorders. Nat Commun. 2021;12:1487.","journal-title":"Nat Commun"},{"key":"1696_CR17","doi-asserted-by":"crossref","unstructured":"Kuang J, Wang J, Li Y, Li M, Zhao M, Ge K, et al. Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis. Cell Metab 2023;35:1752\u201366.e8.","DOI":"10.1016\/j.cmet.2023.07.011"},{"key":"1696_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ymthe.2023.01.018","volume":"31","author":"J Li","year":"2023","unstructured":"Li J, Chen Y, Li R, Zhang X, Chen T, Mei F, et al. Gut microbial metabolite hyodeoxycholic acid targets the TLR4\/MD2 complex to attenuate inflammation and protect against sepsis. Mol Ther. 2023;31:1017\u201332.","journal-title":"Mol Ther"},{"key":"1696_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.5851\/kosfa.2024.e65","volume":"44","author":"HY Jeong","year":"2024","unstructured":"Jeong HY, Moon YS, Cho KK. \u03c9-6 and \u03c9-3 polyunsaturated fatty acids: inflammation, obesity and foods of animal resources. Food Sci Anim Resour. 2024;44:988\u20131010.","journal-title":"Food Sci Anim Resour"},{"key":"1696_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ncpgasthep1067","volume":"5","author":"KN Jeejeebhoy","year":"2008","unstructured":"Jeejeebhoy KN. Benefits and risks of a fish diet-should we be eating more or less? Nat Clin Pract Gastroenterol Hepatol. 2008;5:178\u20139.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1696_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","volume":"16","author":"N Zmora","year":"2019","unstructured":"Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16:35\u201356.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1696_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm1585","volume":"13","author":"A Amadi-Obi","year":"2007","unstructured":"Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1. Nat Med. 2007;13:711\u20138.","journal-title":"Nat Med"},{"key":"1696_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10753-024-02053-y","volume":"48","author":"R Qu","year":"2025","unstructured":"Qu R, Peng Y, Xu S, Zhou M, Yin X, Liu B, et al. RBPJ knockdown promotes M2 macrophage polarization through mitochondrial ROS-mediated notch1-Jagged1-Hes1 signaling pathway in uveitis. Inflammation. 2025;48:133\u201350.","journal-title":"Inflammation"},{"key":"1696_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9:97.","journal-title":"Signal Transduct Target Ther"},{"key":"1696_CR25","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.2174\/1381612821666150316122928","volume":"21","author":"IP Klaska","year":"2015","unstructured":"Klaska IP, Forrester JV. Mouse models of autoimmune uveitis. Curr Pharm Des. 2015;21:2453\u201367.","journal-title":"Curr Pharm Des"},{"key":"1696_CR26","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jhep.2018.02.013","volume":"69","author":"CL Scott","year":"2018","unstructured":"Scott CL, Guilliams M. The role of Kupffer cells in hepatic iron and lipid metabolism. J Hepatol. 2018;69:1197\u20139.","journal-title":"J Hepatol"},{"key":"1696_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2020.03.006","volume":"52","author":"Y Lu","year":"2020","unstructured":"Lu Y, Basatemur G, Scott IC, Chiarugi D, Clement M, Harrison J, et al. Interleukin-33 signaling controls the development of iron-recycling macrophages. Immunity. 2020;52:782\u201393.e785.","journal-title":"Immunity"},{"key":"1696_CR28","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.4049\/jimmunol.1001345","volume":"186","author":"D Kurotaki","year":"2011","unstructured":"Kurotaki D, Kon S, Bae K, Ito K, Matsui Y, Nakayama Y, et al. CSF-1-dependent red pulp macrophages regulate CD4 T cell responses. J Immunol. 2011;186:2229\u201337.","journal-title":"J Immunol"},{"key":"1696_CR29","doi-asserted-by":"crossref","unstructured":"Wang Y, Jin J, Wu G, Wei W, Jin Q, Wang X. Omega-9 monounsaturated fatty acids: a review of current scientific evidence of sources, metabolism, benefits, recommended intake, and edible safety. Crit Rev Food Sci Nutr 2024;65:1857\u201377.","DOI":"10.1080\/10408398.2024.2313181"},{"key":"1696_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/20406223231156826","volume":"14","author":"J Jiang","year":"2023","unstructured":"Jiang J, Chen L, Sun R, Yu T, Jiang S, Chen H. Characterization of serum polyunsaturated fatty acid profile in patients with inflammatory bowel disease. Ther Adv Chronic Dis. 2023;14:20406223231156826.","journal-title":"Ther Adv Chronic Dis"},{"key":"1696_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s10753-019-01172-1","volume":"43","author":"S Bettadahalli","year":"2020","unstructured":"Bettadahalli S, Acharya P, Talahalli R. Evidence on n-3 fatty acids and oleic acid role in retinal inflammation and microvascular integrity: insight from a hyperlipidemic rat model. Inflammation. 2020;43:868\u201377.","journal-title":"Inflammation"},{"key":"1696_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/intimm\/dxz001","volume":"31","author":"T Ishihara","year":"2019","unstructured":"Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Int Immunol. 2019;31:559\u201367.","journal-title":"Int Immunol"},{"key":"1696_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41423-023-01011-2","volume":"20","author":"E Grajchen","year":"2023","unstructured":"Grajchen E, Loix M, Baeten P, C\u00f4rte-Real BF, Hamad I, Vanherle S, et al. Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity. Cell Mol Immunol. 2023;20:666\u201379.","journal-title":"Cell Mol Immunol"},{"key":"1696_CR34","doi-asserted-by":"crossref","unstructured":"Pompura SL, Wagner A, Kitz A, LaPerche J, Yosef N, Dominguez-Villar M, et al. Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis. J Clin Investig. 2021;131:e138519.","DOI":"10.1172\/JCI138519"},{"key":"1696_CR35","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","volume":"603","author":"D Paik","year":"2022","unstructured":"Paik D, Yao L, Zhang Y, Bae S, D\u2019Agostino GD, Zhang M, et al. Human gut bacteria produce \u03a4(\u0397)17-modulating bile acid metabolites. Nature. 2022;603:907\u201312.","journal-title":"Nature"},{"key":"1696_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2019;576:143\u20138.","journal-title":"Nature"},{"key":"1696_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647\u201352.","journal-title":"Am J Ophthalmol"},{"key":"1696_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamaophthalmol.2018.2664","volume":"136","author":"P Yang","year":"2018","unstructured":"Yang P, Zhong Y, Du L, Chi W, Chen L, Zhang R, et al. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 2018;136:1025\u201331.","journal-title":"JAMA Ophthalmol"},{"key":"1696_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6691681","volume":"2021","author":"J Wang","year":"2021","unstructured":"Wang J, Wu H, Liu X, Jia H, Lu H. Effect of LPS on cytokine secretion from peripheral blood monocytes in juvenile idiopathic arthritis-associated uveitis patients with positive antinuclear antibody. J Immunol Res. 2021;2021:6691681.","journal-title":"J Immunol Res"},{"key":"1696_CR40","doi-asserted-by":"crossref","unstructured":"Du L, Yip YWY, Ng HK, Ho BM, He JN, Chan SO, et al. Ruxolitinib alleviates uveitis caused by Salmonella typhimurium endotoxin. Microorganisms 2021;9:1481.","DOI":"10.3390\/microorganisms9071481"},{"key":"1696_CR41","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1007\/s00216-019-01874-3","volume":"411","author":"Y Li","year":"2019","unstructured":"Li Y, Zheng X, Liang D, Zhao A, Jia W, Chen T. MCEE 2.0: more options and enhanced performance. Anal Bioanal Chem. 2019;411:5089\u201398.","journal-title":"Anal Bioanal Chem"},{"key":"1696_CR42","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00216-018-0947-4","volume":"410","author":"Y Li","year":"2018","unstructured":"Li Y, Li M, Jia W, Ni Y, Chen T. MCEE: a data preprocessing approach for metabolic confounding effect elimination. Anal Bioanal Chem. 2018;410:2689\u201399.","journal-title":"Anal Bioanal Chem"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01696-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:35:50Z","timestamp":1788514550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01696-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01696-8","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}